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Abstract 
Label-free optical detection of insulin would allow in vitro assessment of pancreatic cell 
functions in their natural state and expedite diabetes-related clinical research and treatment, 
however no existing method has met these criteria at physiological concentrations. Using 
spatially-uniform 3D gold-nanoparticle sensors, we have demonstrated surface-enhanced Raman 
sensing of insulin in the secretions from human pancreatic islets under low and high glucose 
environments without the use of labels such as antibodies or aptamers. Label-free measurements 
of the islet secretions showed excellent correlation among the ambient glucose levels, secreted 
insulin concentrations, and measured Raman-emission intensities. When excited at 785 nm, 
plasmonic hotspots of the densely-arranged 3D gold-nanoparticle pillars as well as strong 
interaction between sulphide linkages of the insulin molecules and the gold nanoparticles 
produced highly sensitive and reliable insulin measurements down to 100 pM. The sensors 
exhibited a dynamic range of 100 pM to 50 nM with an estimated detection limit of 35 pM, 
which covers the reported concentration range of insulin observed in pancreatic cell secretions. 
The sensitivity of this approach is approximately four orders of magnitude greater than 
previously reported results using label-free optical approaches, and it is much more cost-
effective than immunoassay-based insulin detection widely used in clinics and laboratories. 
These promising results may open up new opportunities for insulin sensing in research and 
clinical applications.  
 
Keywords: SERS, Insulin, biosensing, plasmonics, nanoparticles 
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 Hormones are chemical messengers that control a wide variety of functions in the human 
body. Maintaining adequate hormone levels is extremely important for human health and 
disruption to these levels can result in life-debilitating conditions. Simple and easy 
measurements of hormonal secretions ex vivo or in vivo are essential for implementing next 
generation biosensors, allowing convenient monitoring of health and early disease detection.  
 One of the most prevalent diseases resulting from hormonal dysfunction is diabetes, 
which arises from a disruption in the release of insulin in the body.
1-2
 Insulin is a peptide 
hormone which is secreted by beta cells, one of five primary cell-types which populate 
pancreatic cellular clusters known as islets. The concentration of insulin secreted from beta cells 
in plasma has been reported to vary between 100 pM (fasting) and 2 nM (about 1 hour after 
glucose intake) in non-diabetic individuals.
3-4
 In diabetic individuals, functional damage to the 
beta cells reduces or inhibits their ability to release insulin. One of the leading methodologies for 
treatment of type-1 diabetes is pancreatic islet transplantation, where healthy islets harvested 
from deceased donors are transplanted into diabetic patients.
5-6
 Since the number of donors is 
limited, methodologies that can improve the efficiency and success of the transplantation process 
are urgently needed. Before transplantation these islets are screened for their viability and 
functional response to changing glucose concentration in order to reduce the chances of 
transplant failure.
7-9
 Sensors capable of detecting secretion of insulin from beta cells in a cost-
effective, label-free manner with minimal stress to the cells can serve vital roles in clinical 
quality assessment of islets. External monitoring of insulin concentration can also help in disease 
diagnosis and management as well as prevent potentially fatal insulin overdoses or hypoglycemia 
in diabetic patients.
10
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Various sensing methods have been previously explored for insulin detection including 
radioimmunoassays,
11
 mass-spectrometry,
12
 photoluminescence,
13
 electrochemical methods,
14
 
electrophoresis-dependent immunoassays,
15-16
 surface plasmon-resonance (SPR)-based 
competitive binding assays,
17
 and fluorescence resonance energy transfer (FRET).
18
 The optical 
detection techniques such as SPR, photoluminescence, and FRET suffer from poor sensitivity 
and cannot detect insulin at physiologically observed picomolar concentrations.
13, 17-18
 
Electrochemical impedance spectroscopy and immunoassays have reported more sensitive 
insulin-specific detection, however these methods have primarily relied on capture agents such 
as antibodies for detection.
11, 14, 19
 These antibodies are not only expensive, but have also been 
shown to disrupt the natural behavior of live cells.
20-21
  
For applications such as pancreatic islet transplantation, a label-free, optical sensing 
method capable of performing ultrasensitive detection of insulin without using capturing agents 
can help improve the cost-effectiveness as well help the islet cells remain as close to their natural 
state as possible during the pre-surgical screening process. Surface-enhanced Raman 
spectroscopy (SERS) is an ideal approach for optical label-free sensing because it identifies 
targeted molecules based on their unique vibrational and rotational signatures.
22-26
 Application of 
SERS for hormone detection appears relatively unexplored due to minimal experimental success: 
previously reported SERS-based quantitative insulin sensors were limited due to weakly-
enhancing substrates made of randomly dispersed nanoparticles resulting in micromolar 
detection sensitivity, approximately 2 to 4 orders of magnitude larger than clinically-relevant 
insulin levels.
27-30
  
In this study, we report highly sensitive SERS-based insulin sensing at clinically relevant 
concentrations using a non-resonant SERS substrate with strong signal enhancement and wafer-
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scale uniformity.
31-34
 The sensors were batch-fabricated using a simple two-step process that 
produced 3 dimensional (3D) gold-nanoparticle (Au-NP) clusters packed densely in a vertical, 
pillar-like arrangement.
33
 The 3D pillar-like geometry of the clusters adsorb and excite insulin 
molecules with vertically packed plasmonic hotspots uniformly over a large surface area for 
enhanced Raman emissions. This geometry provides significantly stronger and more spatially 
uniform enhancement than previously used substrates and greatly improved the detection limit.
31-
36
 The obtained result is several orders of magnitude better than previously reported values 
produced using SERS approaches,
27-30
 and the detection limit of the substrate is estimated as 35 
pM. Using our method, we characterized the insulin concentrations in pancreatic islet secretions 
that were collected under low and high glucose conditions. The measurements obtained using our 
approach showed excellent consistency and paralleled the concentrations obtained using an 
enzyme-linked immunosorbent assay (ELISA).  
The fabrication of the SERS substrate was described in detail by Yang et al.
33
 A 
summary of the fabrication has been provided in the Supporting Information (Figure S1). The 
cross-sectional view of the 3D Au-NP SERS substrate acquired using scanning electron 
microscopy (SEM) is shown in Figure 1a. The SEM image reveals a dense, vertical arrangement 
of gold nanoparticle clusters that, based on experimental results, provide plasmonic hotspots 
necessary for ultrasensitive optical detection.
33
 SEM images in Figure 1 (b) and (c) show Au-NP 
clusters before and after adsorption of 1 µM insulin, respectively. Raman spectra obtained from 
powdered insulin (Figure 1d) and 3D Au-NP clusters incubated in 1 mM insulin (Figure 1e) were 
collected as reference Raman signatures for insulin sensing and show consistent peak intensities 
and location. The most intense peak at 1002 cm
-1 
corresponding to the ring-breathing mode of 
aromatic phenylalanine was used to monitor the change in Raman intensity as a function of 
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insulin concentration.
37
 Measurements were performed at the center of each chip and at four 
additional points -- top, bottom, left, and right, about 0.5 mm away from the center location -- to 
characterize the Raman intensity and spatial uniformity. The change in SERS signal intensity as 
a function of insulin concentration between 100 pM to 50 nM is shown in Figures 2 (a) and (b). 
The 1002 cm
-1 
peak was identifiable at 100 pM and a linear increase in the Raman intensity was 
observed as the insulin concentration increased from 100 pM to 10 nM. The Raman intensity 
reached saturation at insulin concentrations greater than 50 nM, which indicates an almost 
complete monolayer coverage. Insulin can exist in solutions as a hexamer (~ 5 nm in diameter 
and 3.5 nm in height) in the presence of zinc ions at neutral pH, as a dimer ( ~ 4.5 nm diameter 
and ~ 2 nm in height) or as a monomer (~ 2 nm diameter and height ~ 2 nm).
38
 As no zinc ions 
were added to insulin containing buffers, the molecules are expected to be in a monomer-dimer 
equilibrium. Given the size of insulin molecules, even if there were a second layer sitting on top 
of the first layer, the second layer would be too far away from the surface to significantly benefit 
from the near-field enhancement on the surface, and the Raman-emission contribution by the 
second and/or third layers would be minimal.
39
 The signal-to-noise ratio (SNR) at 100 pM was 
calculated to be approximately 8.5, and the theoretical detection limit was calculated to be 35 pM 
for a minimum acceptable SNR of 3.  
For typical SERS substrates, even a small displacement of the incident laser could often 
lead to a huge change in Raman signal intensity due to non-uniformly distributed SERS hotspots. 
In order to improve the consistency of SERS measurements, recent focus has been placed on 
improving the chip-scale measurement uniformity either by implementing better substrates,
31-34
 
or employing better measurement strategies such as areal averaging,
35-36
 which involves scanning 
a larger area on the substrate to collect and average more Raman-signal data points as opposed to 
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making a single point measurement. Two-dimensional (2D) mapping of Raman spectra was 
performed over a 1×1 mm
2
 area with a step size of 20 µm on a chip coated with a 10-nM insulin 
solution (Figure 2c). The relative standard deviation (RSD) of the signal fluctuation (calculated 
using five points distributed across the substrate as mentioned earlier) was 4.3%, indicating 
uniform enhancement of Raman signal over a large area of the sensor. A histogram of the Raman 
signals obtained over the mapped region also reveals a very narrow intensity distribution and 
indicates uniform enhancement (Figure 2d). Both highly uniform 2D areal scan results (Figure 
2c, d) and the saturation of the Raman-intensity curve support that the insulin coverage on the 
surface is a monolayer – or the major contribution comes from the monolayer, and the transport 
mechanism to the surface is a relatively uniform diffusion process. Areal averaging was also 
explored to check if we can further improve the spatial uniformity of Raman measurements. 
Figure 2e shows the RSD as a function of the scan area used for averaging. The results show that 
increasing the averaging scan area improves the measurement uniformity. For example, 
increasing the average scan area from 50×50 µm
2
 to 400×400 µm
2
 reduces the RSD from 3.6% 
to 1.7%. However, it should be noted the improvement in measurement uniformity from areal 
averaging is small, only about 1-3%, which is a testament to the excellent spatial uniformity of 
signal obtained from the 3D Au-NP substrate. This excellent spatial uniformity of SERS 
measurements also indicates a complete and uniform coverage of insulin on the substrate. 
In order to demonstrate a practical, rapid detection of low-level insulin using the SERS 
substrate, a 200 µL drop of 100-pM insulin solution was applied to the surface of fresh SERS 
chips and dried by placing on a hotplate (without stirring) at 50˚C for 30 minutes. The locations 
and intensities of the Raman peaks measured from the evaporation-prepared samples (Figure 2f) 
matched the substrates incubated in insulin solutions for 12 hours. The droplet is typically 0.5 cm 
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in diameter, and signal was collected from central regions of the placed droplet, where insulin 
transport should be governed by diffusion and any thermal gradient-derived convective currents, 
thus avoiding the edges where evaporation-driven concentrating ring effects are observed. As 
mentioned earlier, even if more than one layer of molecules were assembled on the surface, the 
second layer would be too far away from the surface to benefit from the near-field enhancement 
on the surface as the Raman-emission contribution by the second and/or third layers would be 
minimal.
39
 A <10% SNR reduction was observed in the faster evaporation-detection technique 
and the minimum detectable concentration was calculated to be approximately 40 pM.  
From our measurements, the enhancement factor of the substrate for sensing insulin was 
calculated to be 3×10
7
.
40
 This enhancement primarily originates from the exceptionally strong 
plasmonic (electromagnetic) enhancement of the 3D Au-NP clusters. Capture of insulin on the 
gold substrate can be mediated through two possible interactions: a) hydrophobic regions of the 
insulin molecules can promote adsorption onto the substrate, which exhibits extreme 
hydrophobicity with a measured water-substrate contact angle of 140 degrees and b) through 
strong binding interaction between the disulphide bonds of insulin molecules and the gold atoms 
of the SERS substrate.
41-43
 The chemical interaction between sulphur and gold atoms is well 
known and has been extensively utilized by researchers in the form of thiol-gold linkages.
44-45
 
These interactions between the insulin molecules and gold substrate can further contribute 
towards enhancement of Raman signal.
46
 
We then utilized our label-free sensing method to assess the functionality of human 
pancreatic islets. Secretions from the islets were collected using a flow-culture system under low 
glucose (3 mM) and high glucose (17 mM) environments as discussed in the experimental 
section (Supporting information file).
8
 We established the insulin concentrations of the collected 
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secretion samples by performing the ELISA on an aliquot extracted from each secretion sample.  
We applied the collected secretion samples to 3D Au-NP cluster chips and measured SERS 
signals (Figure 3). Difference in the SERS intensity from low-glucose and high-glucose 
secretions was clearly visible. Then we compared the SERS signals of the islet secretions with 
those obtained previously in the calibration test performed on insulin in PBS buffer. A regression 
analysis was carried out on the islet-secretion measurements by fitting a line with the slope 
obtained from the calibration test (Figure 3b). While the slopes are the same, the y-intercept of 
the line fitted to the islet-secretion measurements (Figure 3b, y-intercept = 74.8) is approximately 
six times larger than that of the line fitted to the calibration-test results (inset of Figure 2b, y-
intercept = 12.6), indicating that the line was shifted upward for the islet case. This was due to 
the presence of other molecules (primarily HSA) in the islet secretion buffer, leading to an 
increase in the background intensity bias that pushed up the overall spectral intensity. Other than 
the difference in the background intensity bias, our islet-secretion measurements were highly 
consistent with the calibration measurements made using insulin in PBS. In the islet-secretion 
measurements, the Raman intensity of the insulin peak at 1002 cm
-1
 consistently increased as a 
function of increasing glucose and insulin concentrations (Figure S2). The islet measurements 
also showed a highly linear relationship with the ELISA measurements as shown in Figure 3b, 
and this linear relationship was well described by a line whose slope is the same as that obtained 
in the calibration test. The coefficient of determination (R
2
) was 0.97, indicating an excellent 
linear fit (Figure 3b).   
The RSDs for the Raman signals from islet-secretion samples were calculated as 5 % and 
5.3 % for the low- and high-glucose samples, respectively, and showed a small increase as 
compared to 4.3 % obtained from calibration-test samples (Figure 2e). There was no significant 
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change in the calculated detection limit for the islet secretions, which was estimated at 
approximately 36 pM using a SNR threshold of 3. Although the constant bias of the background 
signal (indicated by the elevated y-intercept in Figure 3b as compared to y-intercept in Figure 2b 
(inset)) increased by a factor of six, the mean noise level (after subtracting the background bias) 
remained almost the same as in the islet-measurement case.  As a result, the SNR remains almost 
constant from the insulin-in-PBS case to the islet case. And, the slope of the Raman-intensity vs. 
insulin concentrations produced using our approach remained the same in both cases as shown in 
Fig. 3b even if the background bias increased in the islet case. The detection limit in this case 
signifies the minimum detectable change in insulin concentration in the target concentration 
range, which is important to characterize islet performance.  
The increase in the background noise (after subtracting the constant bias) in the islet case 
was minimal because the influence of other molecules on our measurements was very weak. As 
glucose has a weak Raman cross-section and poor adhesion to metals,
47-48
 change in glucose 
concentration has no influence on obtained Raman signal. The influence on Raman signals from 
other hormones such as glucagon, amylin, somatostatin, and pancreatic polypeptide whose 
concentration could change in response to elevating glucose levels was considered as a potential 
source of error. However, the physiological concentration of glucagon released in islet secretions 
is less than 17 pM, which is lower than the detection limit of the sensor, and its influence was 
considered insignificant.
49-50
 The concentration levels of amylin and somatostatin in the islet 
secretion are also very small, about 1/100 and 1/25 of the insulin concentration, respectively.
51-52
 
And, pancreatic polypeptide does not show the Raman peak at 1002 cm
-1
 from phenylalanine.
53
 
Hence, when detecting insulin in islet secretion using the peak at 1002 cm
-1
, the influence of 
other hormones on our measurements can be ignored. 
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Conclusion and Discussion 
Using a Raman-enhancing plasmonic platform, we have demonstrated highly sensitive 
optical detection of insulin at physiological and clinically-relevant concentrations. The chip-scale 
uniformity of the measurements is excellent, and we successfully characterized the insulin levels 
in the pancreatic islet secretions. To the best of our knowledge, this is the first demonstration of 
clinically-relevant, spatially uniform protein sensing on-chip using a highly enhancing non-
resonant SERS substrate, whereas other reports have achieved highly uniform and sensitive 
detection only with smaller molecules such as Rhodamine 6G.
31-34
 Based on surface interactions, 
other gold-based SERS surfaces should elicit similar adsorption behavior and allow detection of 
insulin in principle although the resulting accuracy and sensitivity of qualitative sensing may 
vary from substrate to substrate. The limit of detection far exceeds previously reported label-free 
optical sensing-based results and can be further improved by using molecule-concentrating 
techniques and post-measurement signal processing.
54-56
 The work presented in this manuscript 
can directly lead to development of convenient label-free optical sensors for large-scale on-chip 
screening of pancreatic islets required for islet transplantation therapy. The future direction will 
also be aimed at improving the specificity of hormone detection using these substrates in media 
such as blood. Techniques such as complex spectrum analysis including weighted analysis of 
multiple peaks, as well as application of small and cost-effective linkers such as aptamers with 
similar or better affinity for insulin as existing antibodies need to be developed towards this goal. 
These advancements can lead to cost-effective, easy-to-use, and sufficiently accurate insulin 
sensors, not yet commercially available, for measurements at home, laboratories and clinics. 
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Figures 
 
Figure 1: (a) Cross-sectional SEM image showing the vertical pillar-like 3D arrangement of the 
Au-NP clusters on the substrate. (b) SEM of a substrate before and (c) after insulin incubation 
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(top view). (d) Raman spectra of human insulin powder and (e) a SERS substrate incubated in 1 
mM insulin solution. The most intense peak at 1002 cm
-1 
corresponds to the ring-breathing mode 
of aromatic phenylalanine and was used to monitor changes in Raman intensity as a function of 
insulin concentration. 
 
Page 13 of 23
ACS Paragon Plus Environment
ACS Sensors
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
14 
 
Figure 2: (a) SERS spectra of 100 pM, 500 pM, 1 nM, 5 nM, 10 nM, 50 nM human insulin 
solutions highlighting the target peak at 1002 cm
-1
. (b) Experimentally measured relationship 
between the insulin concentration and SERS intensity; the inset shows a linear relationship 
between the Raman intensity and concentration from 100 pM to 10 nM. (c) 2D Raman-intensity 
mapping of a SERS chip (1×1 mm
2
) after incubating in a 10 nM insulin solution. The RSD of the 
Raman signal over the 1×1 mm
2
 area was found to be 4.3%, demonstrating excellent spatial 
uniformity. (d) Histogram showing the narrow distribution of Raman intensity over the mapped 
region. (e) Graph showing the mean and standard deviation of Raman signals collected from the 
sample as a function of the scan size used for areal averaging. The relative standard deviation 
could be further improved down to 1.7% using areal averaging. (f) A SERS spectrum captured 
from a 3D Au-NP SERS chip coated with a drop of 100-pM human insulin solution followed by 
rapid on-chip evaporation.  
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Figure 3: a) Illustration of using a 3D Au-NP SERS chip for analysis of pancreatic islet 
secretions. Secretions from islets were obtained under low and high glucose conditions. Insulin 
concentrations in these secretions were first measured using ELISA. The secretion samples were 
then added to SERS substrates to measure the Raman spectra and intensity. b) Raman signal 
intensities measured on various islet secretions (the vertical axis) correlated with the 
concentrations of insulin in the samples obtained using the ELISA method (the horizontal axis). 
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The red line whose slope is the same as that obtained in the calibration test (inset of Figure 2(b)) 
exhibited the coefficient of determination (R
2
) close to 1, indicating an excellent fit.  
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